CD180 CAR-T

· Institute of Hematology & Blood Diseases Hospital, China

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD180 CAR-T, covering 2025-08-06 to 2025-08-06. Get the full timeline:

Most recent: Clinical Trial Update: CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies [Phase 1]